280 related articles for article (PubMed ID: 31734646)
1. Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.
He D; Lasek AW
Mol Pharmacol; 2020 Feb; 97(2):123-131. PubMed ID: 31734646
[TBL] [Abstract][Full Text] [Related]
2. Neurotensin triggers dopamine D2 receptor desensitization through a protein kinase C and beta-arrestin1-dependent mechanism.
Thibault D; Albert PR; Pineyro G; Trudeau LÉ
J Biol Chem; 2011 Mar; 286(11):9174-84. PubMed ID: 21233215
[TBL] [Abstract][Full Text] [Related]
3. ARF6 and GASP-1 are post-endocytic sorting proteins selectively involved in the intracellular trafficking of dopamine D₂ receptors mediated by GRK and PKC in transfected cells.
Cho DI; Zheng M; Min C; Kwon KJ; Shin CY; Choi HK; Kim KM
Br J Pharmacol; 2013 Mar; 168(6):1355-74. PubMed ID: 23082996
[TBL] [Abstract][Full Text] [Related]
4. The dopamine D2 receptor can directly recruit and activate GRK2 without G protein activation.
Pack TF; Orlen MI; Ray C; Peterson SM; Caron MG
J Biol Chem; 2018 Apr; 293(16):6161-6171. PubMed ID: 29487132
[TBL] [Abstract][Full Text] [Related]
5. The histamine H3 receptor modulates dopamine D2 receptor-dependent signaling pathways and mouse behaviors.
Xu J; Pittenger C
J Biol Chem; 2023 Apr; 299(4):104583. PubMed ID: 36871761
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area.
Dutton JW; Chen H; You C; Brodie MS; Lasek AW
Addict Biol; 2017 May; 22(3):665-678. PubMed ID: 26752591
[TBL] [Abstract][Full Text] [Related]
7. Apatinib reverses alectinib resistance by targeting vascular endothelial growth factor receptor 2 and attenuating the oncogenic signaling pathway in echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene-positive lung cancer cell lines.
Chen Y; Ma G; Su C; Wu P; Wang H; Song X; Yu Q; Zeng A; Zhou S
Anticancer Drugs; 2018 Nov; 29(10):935-943. PubMed ID: 30074936
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor.
Namkung Y; Sibley DR
J Biol Chem; 2004 Nov; 279(47):49533-41. PubMed ID: 15347675
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases.
Liu H; Ma H; Zeng X; Wu C; Acharya S; Sudan SK; Zhang X
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373182
[TBL] [Abstract][Full Text] [Related]
11. Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase, and dynamin.
Nimitvilai S; McElvain MA; Brodie MS
J Pharmacol Exp Ther; 2013 Jan; 344(1):253-63. PubMed ID: 23019137
[TBL] [Abstract][Full Text] [Related]
12. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
So CH; Verma V; O'Dowd BF; George SR
Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of eight types of ALK fusion variant to alectinib in ALK-transformed cells.
Furugaki K; Harada N; Yoshimura Y
Anticancer Drugs; 2022 Feb; 33(2):124-131. PubMed ID: 34520436
[TBL] [Abstract][Full Text] [Related]
14. RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.
Luessen DJ; Hinshaw TP; Sun H; Howlett AC; Marrs G; McCool BA; Chen R
Neuropharmacology; 2016 Nov; 110(Pt A):297-307. PubMed ID: 27528587
[TBL] [Abstract][Full Text] [Related]
15. Signaling by dopamine regulates D2 receptors trafficking at the membrane.
Tirotta E; Fontaine V; Picetti R; Lombardi M; Samad TA; Oulad-Abdelghani M; Edwards R; Borrelli E
Cell Cycle; 2008 Jul; 7(14):2241-8. PubMed ID: 18635969
[TBL] [Abstract][Full Text] [Related]
16. cMyc and ERK activity are associated with resistance to ALK inhibitory treatment in glioblastoma.
Berberich A; Schmitt LM; Pusch S; Hielscher T; Rübmann P; Hucke N; Latzer P; Heßling B; Lemke D; Kessler T; Platten M; Wick W
J Neurooncol; 2020 Jan; 146(1):9-23. PubMed ID: 31776900
[TBL] [Abstract][Full Text] [Related]
17. Disruption of dopamine D1/D2 receptor complex is involved in the function of haloperidol in cardiac H9c2 cells.
Lencesova L; Szadvari I; Babula P; Kubickova J; Chovancova B; Lopusna K; Rezuchova I; Novakova Z; Krizanova O; Novakova M
Life Sci; 2017 Dec; 191():186-194. PubMed ID: 29054453
[TBL] [Abstract][Full Text] [Related]
18. Modulation of A₂a receptor antagonist on D₂ receptor internalization and ERK phosphorylation.
Huang L; Wu DD; Zhang L; Feng LY
Acta Pharmacol Sin; 2013 Oct; 34(10):1292-300. PubMed ID: 23933651
[TBL] [Abstract][Full Text] [Related]
19. Reducing Ventral Tegmental Dopamine D2 Receptor Expression Selectively Boosts Incentive Motivation.
de Jong JW; Roelofs TJ; Mol FM; Hillen AE; Meijboom KE; Luijendijk MC; van der Eerden HA; Garner KM; Vanderschuren LJ; Adan RA
Neuropsychopharmacology; 2015 Aug; 40(9):2085-95. PubMed ID: 25735756
[TBL] [Abstract][Full Text] [Related]
20. Receptor, Ligand and Transducer Contributions to Dopamine D2 Receptor Functional Selectivity.
Peterson SM; Pack TF; Caron MG
PLoS One; 2015; 10(10):e0141637. PubMed ID: 26516769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
